Senseonics (NYSE:SENS) Shares Down 4.9% – Here’s What Happened

Shares of Senseonics Holdings, Inc. (NYSE:SENS) were down 4.9% on Wednesday . The company traded as low as $0.70 and last traded at $0.72. Approximately 2,561,694 shares changed hands during trading, a decline of 59% from the average daily volume of 6,253,141 shares. The stock had previously closed at $0.76.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SENS. HC Wainwright reissued a “buy” rating and issued a $2.00 price target on shares of Senseonics in a report on Wednesday, March 5th. StockNews.com started coverage on Senseonics in a research note on Thursday, December 26th. They set a “sell” rating for the company.

Senseonics Stock Performance

The company’s 50-day moving average is $0.89 and its two-hundred day moving average is $0.56. The company has a market capitalization of $469.33 million, a P/E ratio of -5.54 and a beta of 1.17. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Senseonics (NYSE:SENS) last issued its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.09). Senseonics had a negative return on equity of 842.25% and a negative net margin of 362.30%. During the same quarter in the prior year, the business posted ($0.07) earnings per share. Equities analysts anticipate that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Senseonics

Several hedge funds have recently added to or reduced their stakes in SENS. FMR LLC raised its holdings in shares of Senseonics by 48,267.2% during the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after acquiring an additional 179,103 shares in the last quarter. Ridgecrest Wealth Partners LLC purchased a new position in shares of Senseonics during the fourth quarter worth approximately $60,000. Jane Street Group LLC lifted its holdings in shares of Senseonics by 6,694.1% in the 4th quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock worth $3,203,000 after acquiring an additional 6,028,726 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of Senseonics during the 4th quarter valued at $720,000. Institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.